Clinical Trial

Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain

Study acronym: OIME
Recruiting
View on ClinicalTrials.gov →
Summary
The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the treatment of IBS pain via an ambulatory trial.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-04-19; most recent amendment 2025-09-08.
Status change: Not Yet Recruiting → Recruiting 2025-09-08
Trial Details
NCT Number NCT06381921
Lead Sponsor University of Connecticut
Collaborators: Yale University
Conditions Abdominal Pain
Enrollment 120 participants
Start Date 2025-09-08
Primary Completion 2027-10-31 (estimated)
Study Completion 2029-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-09-15